Intermittent Catheters Market Size, Growth, and Trends Forecast 2025-2033
Global Intermittent Catheters Market Statistics: USD 4.9 Billion Value by 2033
Summary:
- The global intermittent catheters market size reached USD 2.9 Billion in 2024.
- The market is expected to reach USD 4.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.72% during 2025-2033.
- North America leads the market, accounting for the largest intermittent catheters market share.
- Urinary incontinence holds the biggest market share on account of the increasing awareness among individuals about urine incontinence.
- Female length catheter accounts for the largest market share due to the rising need to lower the risk of injury or pain.
- The increasing prevalence of urinary disorders, such as urinary incontinence, neurogenic bladder, and benign prostatic hyperplasia (BPH), among the masses around the world is catalyzing the demand for intermittent catheters.
- Innovations in catheter technology are leading to the creation of hydrophilic-coated and antimicrobial catheters that offer enhanced patient comfort and lower infection rates.
Industry Trends and Drivers:
- Growing Prevalence of Urinary Disorders:
The increasing prevalence of urinary disorders, such as urinary incontinence, neurogenic bladder, and benign prostatic hyperplasia (BPH), among the masses around the world is catalyzing the demand for intermittent catheters. As these conditions often impair normal bladder function, patients require regular catheterization to manage their urinary output. The rising number of individuals, especially the elderly and those with spinal cord injuries or neurological conditions, are experiencing these disorders, which is bolstering the market growth. Additionally, lifestyle factors, including poor dietary habits, obesity, and sedentary living, are expanding the market for intermittent catheters as a necessary tool for effective management.
- Technological Advancements and Product Innovations:
Innovations in catheter technology are leading to the creation of hydrophilic-coated and antimicrobial catheters that offer enhanced patient comfort and lower infection rates. These advancements address key user concerns, such as discomfort during insertion and the risk of urinary tract infections (UTIs). In addition, advancements like pre-lubricated and single-use disposable catheters are making self-catheterization more accessible and convenient for patients. As technology continues to evolve, new products are emerging that improve safety and ease of use, thereby increasing their adoption among patients and healthcare providers alike.
- Increasing Awareness and Adoption in Home Care:
The rising awareness among individuals about the benefits of intermittent catheterization over other forms, such as indwelling catheters, is supporting the market growth. Healthcare professionals and organizations are increasingly promoting intermittent catheters due to their lower risk of infection and greater convenience for patients. Besides this, rising preferences for at-home care solutions, along with high healthcare costs, are contributing to the market growth. The shift towards home-based care and self-management, especially among the aging population, is impelling the market growth. Patients are seeking comfortable and effective urinary management solutions that can be used independently.
Request for a sample copy of this report: https://www.imarcgroup.com/intermittent-catheters-market/requestsample
Intermittent Catheters Market Report Segmentation:
By Product:
- Uncoated Intermittent Catheter
- Coated Intermittent Catheter
- Antimicrobial
- Hydrophilic
- Others
Uncoated intermittent represents the largest segment as it enhances patient comfort and infection control.
By Indication:
- Urinary Incontinence
- Surgery (Major Surgery)
- Spinal Cord Injury
- Others
Urinary incontinence holds the biggest market share on account of the increasing awareness among individuals about urine incontinence.
By Category:
- Male Length Catheter
- Kids Length Catheter
- Female Length Catheter
Female length catheter accounts for the largest market share due to the rising need to lower the risk of injury or pain.
By End User:
- Hospitals
- Medical Research Centers
- Ambulatory Surgical Centers
Hospitals exhibit a clear dominance in the market, driven by their ability to handle a higher volume of patients.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America enjoys a leading position in the intermittent catheters market, which can be attributed to the high prevalence of urological disorders.
Top Intermittent Catheters Leaders:
The intermittent catheters market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:
- B. Braun Melsungen AG
- Becton Dickinson and Company
- Coloplast A/S
- Cure Medical LLC (Convatec Group plc)
- Hollister Incorporated
- Hunter Urology
- Medical Technologies of Georgia Inc.
- Pennine Healthcare Ltd.
- Teleflex Inc
- Wellspect Limited (Dentsply Sirona).
Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian